NCT05818592View on ClinicalTrials.gov

Screening for Atrial Fibrillation With Self Pulse Monitoring

NACompletedINTERVENTIONAL
Enrollment

526

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Atrial Fibrillation New Onset
Interventions
OTHER

Self-Pulse Monitoring

Participants will manually monitor pulse for irregularities.

Trial Locations (1)

27599

University of North Carolina, Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER